Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 25, 2025 15:26 ET | Source: Robbins LLP

RXST Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Against RxSight, Inc.

Robbins LLP is Investigating Allegations that RxSight, Inc. (RXST) Misled Investors Regarding Demand for its Products
July 15, 2025 17:19 ET | Source: Robbins LLP

CNC Class Action Alert: Robbins LLP Reminds Centene Corporation Stockholders of the Lead Plaintiff Deadline in the Class Action Against CNC

Robbins LLP is Investigating Allegations that Centene Corporation (CNC) Misled Investors Regarding its Business Prospects
July 15, 2025 17:18 ET | Source: Robbins LLP

Robbins LLP is Investigating the Officers and Directors of RxSight, Inc. (RXST) to Determine if They Breached Fiduciary Duties Owed to Shareholders

Robbins LLP is Investigating the Officers and Directors of RxSight, Inc. (RXST) to Determine if They Breached Fiduciary Duties Owed to Shareholders
June 25, 2025 04:00 ET | Source: Alvotech

Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)

REYKJAVIK, Iceland and PISCATAWAY, N.J. and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of...
June 17, 2025 20:48 ET | Source: Robbins LLP

Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the Motion to Dismiss

iRhythm misled investors by promoting Zio AT as a real-time monitor for high-risk patients, inflating stock prices that dropped when the truth emerged.
June 13, 2025 20:28 ET | Source: Robbins LLP

RCKT Investor Notice: Robbins LLP Reminds Shareholders of the Class Action Lawsuit Against Rocket Pharmaceuticals, Inc.

Robbins LLP is Investigating Allegations that Rocket Pharmaceuticals, Inc. (RCKT) Misled Investors Regarding the Viability and Efficacy of RP-A501
June 12, 2025 18:08 ET | Source: Robbins LLP

WST Lead Plaintiff Deadline Approaching – WST Stockholders Should Contact Robbins LLP for Information About Leading the West Pharmaceutical Services, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that West Pharmaceutical Services, Inc. (WST) Misled Investors Regarding the Company's Business Prospects
June 06, 2025 18:21 ET | Source: Robbins LLP

URGN Investors with Large Losses Should Contact Robbins LLP for Information About the Class Action Lawsuit Against UroGen Pharma Ltd.

Robbins LLP is Investigating Allegations that UroGen Pharma Ltd. (URGN) Failed to Conduct a Proper Trial for its Lead Drug Candidate
June 02, 2025 19:36 ET | Source: American Board of Obstetrics and Gynecology

Clarifying ABOG's Mission and the Certification Process

Dallas, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- The American Board of Obstetrics and Gynecology (ABOG) acknowledges the perspectives and concerns raised by attorneys general regarding the safety...
May 25, 2025 08:30 ET | Source: Robbins LLP

Organon & Co. Investor Notice: Robbins LLP Reminds Investors of the Class Action Against OGN

Robbins LLP is Investigating Allegations that Organon & Co. (ORG) Misled Investors Regarding its Debt Reduction Strategy

Next Page keyboard_arrow_right